Brucke Financial Inc. Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)
Brucke Financial Inc. has acquired a new position in UnitedHealth Group (NYSE:UNH), purchasing 907 shares valued at approximately $492,000 during the fourth quarter. Other institutional investors also increased their stakes in the company. Notably, insiders have made significant purchases, with Director Kristen Gil acquiring 3,700 shares and Director Timothy Patrick Flynn acquiring 1,533 shares. Analysts have recently adjusted their target prices for UNH, with ratings ranging from "strong buy" to "sell." The stock opened at $295.37, with a market cap of $267.94 billion.
Brucke Financial Inc. bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 907 shares of the healthcare conglomerate's stock, valued at approximately $492,000.
Get UnitedHealth Group alerts:
- 3 Trades Members of Congress Are Making Right Now
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Waycross Partners LLC raised its position in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock valued at $14,060,000 after buying an additional 658 shares during the last quarter. Sherbrooke Park Advisers LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $515,000. Full Sail Capital LLC raised its position in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after buying an additional 33 shares during the last quarter. Soros Fund Management LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $39,413,000. Finally, Silvercrest Asset Management Group LLC grew its holdings in shares of UnitedHealth Group by 47.8% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock valued at $19,625,000 after purchasing an additional 12,550 shares in the last quarter. Institutional investors own 87.86% of the company's stock.
Insider Activity
In other news, Director Kristen Gil acquired 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director now owns 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director now owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock worth $31,607,768 in the last quarter. Corporate insiders own 0.33% of the company's stock.
Wall Street Analysts Forecast Growth
- Will Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off?
A number of research analysts recently weighed in on UNH shares. Wolfe Research cut their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Mizuho dropped their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, Hsbc Global Res lowered shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $441.87.
View Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Price Performance
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
Shares of NYSE UNH opened at $295.37 on Monday. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The firm has a market cap of $267.94 billion, a P/E ratio of 19.06, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business's 50 day moving average price is $452.40 and its 200 day moving average price is $503.72.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter last year, the business earned $6.91 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Profile
(Free Report)UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Investing in Commodities: What Are They? How to Invest in Them
- This Market Sell-Off Might Trigger a Value Rotation Into Pepsi
- Compound Interest and Why It Matters When Investing
- Alphabet Stock Lags—But Waymo May Be Its Hidden Driver
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Trade Desk Silences Critics; Recovery Looks Poised to Continue
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in UnitedHealth Group Right Now?
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
